Your browser is no longer supported. Please, upgrade your browser.
AGN Allergan plc daily Stock Chart
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-5.63 Insider Own0.10% Shs Outstand395.56M Perf Week-7.56%
Market Cap86.03B Forward P/E12.54 EPS next Y17.34 Insider Trans- Shs Float394.87M Perf Month-6.40%
Income-2446.20M PEG- EPS next Q3.38 Inst Own89.80% Short Float1.83% Perf Quarter-20.49%
Sales16.30B P/S5.28 EPS this Y23.00% Inst Trans-0.50% Short Ratio1.39 Perf Half Y-30.12%
Book/sh183.69 P/B1.18 EPS next Y21.86% ROA- Target Price292.63 Perf Year-29.07%
Cash/sh5.75 P/C37.83 EPS next 5Y11.85% ROE- 52W Range195.50 - 340.34 Perf YTD-30.41%
Dividend0.20 P/FCF- EPS past 5Y-50.40% ROI-1.30% 52W High-36.10% Beta0.70
Dividend %0.09% Quick Ratio0.90 Sales past 5Y33.40% Gross Margin71.80% 52W Low11.24% ATR6.25
Employees31200 Current Ratio1.00 Sales Q/Q48.10% Oper. Margin- RSI (14)34.10 Volatility3.19% 2.58%
OptionableYes Debt/Eq0.59 EPS Q/Q86.30% Profit Margin- Rel Volume0.76 Prev Close217.48
ShortableYes LT Debt/Eq0.53 EarningsAug 04 BMO Payout- Avg Volume5.20M Price217.48
Recom1.90 SMA20-8.97% SMA50-5.10% SMA200-20.32% Volume0 Change0.00%
May-13-16Reiterated Mizuho Neutral $250 → $232
Apr-18-16Resumed Goldman Buy $275
Apr-18-16Initiated Guggenheim Neutral
Apr-18-16Downgrade Piper Jaffray Overweight → Neutral $311 → $238
Apr-07-16Resumed Morgan Stanley Overweight $300
Apr-07-16Resumed JP Morgan Overweight
Apr-07-16Reiterated UBS Buy $366 → $300
Apr-07-16Downgrade Susquehanna Positive → Neutral
Apr-06-16Downgrade Mizuho Buy → Neutral $330 → $250
Mar-31-16Reiterated Canaccord Genuity Buy $340 → $320
Feb-23-16Reiterated Mizuho Buy $354 → $330
Feb-23-16Reiterated Deutsche Bank Buy $308 → $339
Feb-19-16Initiated Wells Fargo Outperform
Nov-24-15Reiterated Mizuho Buy $340 → $354
Nov-13-15Reiterated Mizuho Buy $337 → $340
Oct-28-15Reiterated Leerink Partners Outperform $311 → $342
Oct-09-15Initiated Mizuho Buy
Sep-29-15Initiated Nomura Buy
Aug-07-15Reiterated RBC Capital Mkts Outperform $361 → $375
Aug-07-15Reiterated Deutsche Bank Buy $346 → $350
Jun-28-16 08:48AM  Morning Movers: Dow Chemical Gains on Layoffs; Allergan Rises at
08:36AM  Mayne Pharma buys Teva drugs for $US652m AAP
07:49AM  Allergan Says New Research Indicates New Attitude To Beauty As Women Seek To Score Over Youth On Confidence
07:00AM  New Global Research From Allergan Shows New Attitude To Beauty As Women Seek Confidence Over Youth PR Newswire
07:00AM  New Global Research From Allergan Shows New Attitude To Beauty As Women Seek Confidence Over Youth CNW Group
06:05AM  Brexit Bargain Buys: 14 More Stocks Picked by Morgan Stanley
Jun-27-16 08:01PM  Mayne to Buy Generic Drugs From Allergan, Teva for $652 Million at Bloomberg
07:30PM  Mayne Pharma nears deal for Teva assets: source Reuters
06:08PM  Carl Icahn Says Allergan Is Undervalued, Takes a Large Position
05:55PM  Mayne Pharma nears deal for Teva assets -source Reuters
03:59PM  Allergan Plc Value Analysis (NYSE:AGN) : June 27, 2016
02:09PM  Allergan Has Rolled Over Again
08:10AM  Teva's Cinqaero Gets Positive CHMP View, Decision in 2H16
Jun-26-16 10:18AM  3 of Paul Singer's Top 5 Deals in 1st Quarter Involve Technology Stocks
Jun-24-16 06:37PM  Steve Mandel Exits Position in Williams Companies in 1st Quarter
05:21PM  Brexit Sell-Off Hits 3 Big Pharma Bargain Stocks at Motley Fool
02:22PM  Allergan Is Primed for Increase After a Big Decline
09:12AM  Allergan (AGN) Gets FDA Nod for Avycaz Label Expansion
08:56AM  J.P. Morgan Very Positive on 3 Battered Specialty Pharmaceutical Stocks at 24/7 Wall St.
08:49AM  Allergan Plc breached its 50 day moving average in a Bullish Manner : AGN-US : June 24, 2016
Jun-23-16 08:37PM  Why Pfizer (PFE) is a Great Stock to Buy for the Long Run
04:42PM  Better Buy: Valeant Pharmaceuticals International, Inc. vs. Allergan at Motley Fool
11:29AM  Allergan Gets FDA Approval Of sNDA To Update Label For AVYCAZ
11:15AM  Valeant Pharmaceuticals: Now You Downgrade It? at
08:00AM  Allergan Announces FDA Approval of Supplemental New Drug Application (sNDA) for AVYCAZ® (ceftazidime and avibactam) PR Newswire
Jun-22-16 08:18PM  Jim Cramer's 'Mad Money' Recap: We Need More Mergers Right Now
11:09AM  Allergan: Debt Will Not Impede Strong Growth
10:43AM  Impax Laboratories, Inc. -- Moody's: Impax's Debt-Funded Acquisition of Generics Products is Credit Negative at Moody's
10:20AM  Impax (IPXL) Stock Declines on Deal to Buy Generic Products
06:00AM  'Mad Money' Lightning Round: Be Patient on Alcoa
04:04AM  What Do Analysts Think about Valeant?
Jun-21-16 11:52PM  Asian shares mostly up as investors await more Brexit polls AP
07:10PM  Stocks rise after Feds Janet Yellen takes a cautious tone on interest rates at Los Angeles Times
07:02PM  Cramer: Does Anyone Care About the Opportunities in This Market?
05:35PM  Impax Buys Mystery Generics Portfolio From Teva, Allergan
05:01PM  Impax Buying Teva, Allergan Drugs, Clearing Way For Deal Closing
04:51PM  Here's Why Alphabet, Allergan and L Brands Will Take Off in Second Half
03:33PM  Why Is Impax Labs Tumbling 11.7% Today at Motley Fool
01:20PM  $586M deal: Impax buying generic drugs FTC asked Teva and Allergan to sell at
10:40AM  With Acquisitions, Will Impax Become the Next Great Generic Drug Seller? at 24/7 Wall St.
08:47AM  [$$] Teva and Allergan Sell Generic Drugs to Impax In Latest Divestiture at The Wall Street Journal
07:51AM  Impax Agrees To Buy Genetic Products For $586 Million
Jun-20-16 08:01AM  Data Presented at ASM Microbe Highlight In Vitro Antimicrobial Activity of AVYCAZ® (ceftazidime and avibactam) Against Several Species of Enterobacteriaceae Pathogens and Pseudomonas aeruginosa, Including Certain Resistant Strains PR Newswire
Jun-19-16 02:03PM  1 Stock to Invest in Big Pharma at Motley Fool
01:00PM  3 Mutual Funds Poised to Perform in the Future (VGENX, FSPHX) at Investopedia
Jun-17-16 10:00AM  3 High-Growth Stocks You Don't Need to Babysit at Motley Fool
07:00AM  Allergan Carves Middle Path In R&D Spending With 'Open Science'
12:19AM  Allergan Glaucoma Gel Stent Filing Accepted for FDA Review
Jun-16-16 12:55PM  A Look at Visium Asset Managements Top Picks Amid Loud Insider Trading Case at Insider Monkey
Jun-15-16 10:23PM  A legendary CEO did something unimaginable by todays standards, and it tells you everything about how America has changed
05:26PM  Will A New Suitor For Anacor Emerge? at Forbes
03:00PM  Is Investment Banking Peaking? (PFE, AGN) at Investopedia
08:51AM  Teva's Suspension of Marketing for Zecuity Product is Likely to Have Little Impact
08:00AM  Allergan Gets FDA Acceptance Of Premarket Notification Filing For XEN Glaucoma Treatment System
07:31AM  Allergan Announces FDA Acceptance of the 510(k) Premarket Notification Filing for the XEN Glaucoma Treatment System PR Newswire
Jun-14-16 03:36PM  5 Stocks Hedge Funds Love at Motley Fool
08:31AM  Allergan Reaches Out To Family Caregivers Of People With Alzheimer's Disease With New PSA, Website PR Newswire
Jun-13-16 03:56PM  Allergan (AGN) Stock Advances After Dr. Reddy's Deal
10:00AM  Here's why all those big mergers are failing
09:54AM  Teva-Allergan Deal On Track After Divestitures: Citi at
09:07AM  Heres Why These Five Stocks Are In the Spotlight at Insider Monkey
08:50AM  Portfolio managers spotlighting these three hot sectors at CNBC
08:31AM  Allergan to Present New Data from its Anti-Infectives Portfolio at ASM Microbe 2016 in Boston PR Newswire
04:52AM  AEGON NV :AGN-NL: Earnings Analysis: Q1, 2016 By the Numbers : June 13, 2016
02:14AM  [$$] Dr. Reddy's Buying Eight Drugs From Teva at The Wall Street Journal
Jun-12-16 03:08PM  Barron's: The Midyear Roundtable
02:24PM  Billionaire Investors Are Bullish on These Five Stocks at Insider Monkey
06:43AM  Is Acadia Pharmaceuticals' Stock Still a Buy? at Motley Fool
Jun-11-16 11:11AM  George Soros' Worst-Performing Stocks of 2016 So Far at Motley Fool
11:00AM  3 Top Stocks to Buy for Your Kids in June at Motley Fool
09:56AM  Dr. Reddys to Buy Generics From Allergan, Teva for $350 Million at Bloomberg
09:26AM  Dr. Reddys to acquire product portfolio from TEVA for US Market Business Wire
05:55AM  UPDATE 1-India's Dr Reddy's in $350 mln deal to buy 8 U.S. drugs from Teva, Allergan Reuters
05:52AM  India's Dr Reddy's to buy 8 U.S. generic drugs from Teva, Allergan for $350 mln Reuters
12:01AM  [$$] 2016 Midyear Roundtable: 24 Investment Ideas at
Jun-10-16 02:12PM  Has Valeant Gone Bottom Fishing?
11:31AM  Ironwood/Allergan's Linzess sNDA Accepted for FDA Review
11:08AM  Allergan's New Data Suggests Misperceptions May Lead Chronic Migraine To Be Undertreated In Men
08:31AM  Study Reveals Gender Differences in Migraine Treatment PR Newswire
Jun-09-16 02:43PM  Here's Why Ironwood Pharmaceuticals, Inc. Jumped 19.52% in May at Motley Fool
08:31AM  ActuallySheCan(SM) By Allergan Launches Limited Edition #ActuallySheCan(SM) Tank Top Shirts, A Charitable Initiative Supporting Military Women PR Newswire
08:01AM  Ironwood and Allergan Announce Supplemental New Drug Application for 72 mcg Linaclotide in Chronic Idiopathic Constipation Has Been Accepted for FDA Review PR Newswire
Jun-08-16 03:23PM  Pharmaceutical Stocks Hedge Funds Are Bullish on at Insider Monkey
07:30AM  The Allergan Foundation And The Jed Foundation Announce Three-Year $300,000 Scholarship Fund To Support JED Campus Program PR Newswire
Jun-07-16 04:23PM  Options Insight: How to Play Allergan
04:23PM  Options Insight: How to Play Allergan at Bloomberg
01:44PM  Valeant's Share Price Tumbles, Even as Papa Reiterates Plans for Divestitures
11:46AM  Check Out the Long Side of Allergan
08:45AM  Why investor is buying puts in Allergan
08:22AM  Carl Icahn Bets Big on Allergan's CEO at Motley Fool
Jun-06-16 02:11PM  Allergan CEO Brent Saunders on Making -- and Squelching -- Deals
01:38PM  Allergan gets thumbs up from Icahn, CEO says at CNBC
12:18PM  5 Takeaways From Vanity Fair's New Valeant Expose
12:17PM  Best bets in health care
12:01PM  Hedge Fund ValueAct Capital's Valeant Legacy at Forbes
10:48AM  Allergan CEO on deal with Teva
09:30AM  Heres Why These 29 Companies Fell Off the Fortune 500 at Fortune
08:48AM  Allergan Gets FDA Approval For BYVALSON
08:31AM  Kate Bosworth Partners with Allergan to Celebrate Launch of ACZONE® (dapsone) Gel, 7.5% in New York City PR Newswire
08:30AM  Ebix's A.D.A.M. Division Wins Communicator Award for Excellence Marketwired
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Brands, US Medical Aesthetics, International Brands, and Anda Distribution segments. The company offers a portfolio of products that provide treatments for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, and medical aesthetics, as well as dermatology and plastic surgery. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. Allergan plc also distributes generic and branded pharmaceutical products primarily to independent pharmacies, pharmacy chains, pharmacy buying groups, and physicians' offices. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.